COVID 19 is making an unwelcome comeback in the United States, with cases and hospitalizations on the rise as the country heads into the fall season. California has already seen hospitalizations nearly double, and wastewater monitoring confirms that virus levels are climbing across the West, South, and Southeast.
But this time around, the fight against COVID looks very different. Updated vaccines are available, but under new federal policy, only people 65 and older or younger individuals with qualifying health conditions can get them. That restriction put in place by Health Secretary Robert F. Kennedy Jr. has sparked outrage among medical experts and patients alike. Many adults who want the shot can’t get it without jumping through hoops like prescriptions or insurance exceptions.
The backlash has been swift. The American Academy of Family Physicians joined other medical groups in breaking from federal guidance, recommending that all adults, children, and pregnant women should have access to COVID vaccines. Pediatric organizations have also voiced concern, warning that limited access could put more vulnerable groups at risk.
Meanwhile, states aren’t waiting for Washington to act. California, Oregon, and Washington are exploring regional vaccine guidance to ensure broader access. Some local governments are also setting up independent distribution channels, effectively creating a patchwork of rules across the country.
On top of that, the federal shake up has left the CDC’s advisory committee on immunizations dissolved and replaced by vaccine skeptics. Public health experts warn this is eroding trust at a critical moment, with flu and RSV season just around the corner.
Adding to the complexity, a new COVID variant known as XFG or Stratus is spreading quickly. Early data shows it’s more transmissible but not more severe than earlier strains. Still, with fewer protections in place, even a moderate wave could push hospitals back to the brink.
And then there’s long COVID. Millions are still grappling with ongoing symptoms, and while a diagnostic blood test is being developed, there’s no clear treatment yet.
For everyday people, the message feels mixed. Cases are rising, vaccines are harder to get, and politics are once again shaping public health decisions. One thing is clear though, COVID 19 isn’t gone, and how the U.S. handles this surge will set the tone for the months ahead.
